Ji Yeon Baek

National Cancer Center

Papers

1

Total Citations

25

H-Index

1

About

Dr. Ji Yeon Baek is a distinguished surgical oncologist whose research has significantly advanced the treatment of rectal cancer, particularly through the optimization of preoperative chemoradiotherapy protocols. Her most cited work, a phase II multi-institutional clinical trial (KROG 11-02), demonstrated the safety and efficacy of a two-week course of chemoradiotherapy followed by delayed surgery, offering a more patient-friendly alternative to conventional long-course regimens. This landmark study, with 25 citations, has informed clinical guidelines and sparked further investigation into shortening treatment durations without compromising oncologic outcomes. Dr. Baek’s contributions lie at the intersection of radiation oncology and surgical timing, addressing critical questions about tumor response and postoperative recovery. Her work reflects a commitment to evidence-based, patient-centered care, and she continues to shape the field through collaborative trials within the Korean Radiation Oncology Group (KROG). For students and researchers, Dr. Baek’s research exemplifies how rigorous clinical investigation can translate into tangible improvements in cancer management, reducing treatment burden while maintaining efficacy.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer: A phase II multi-institutional clinical trial (KROG 11-02)
25 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: National Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago